NATHBIOGEN — Nath Bio-Genes (I) Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesAdventurousMicro CapSuper Stock

Annual income statement for Nath Bio-Genes (I), fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,309	2,799	3,076	2,784	3,014
Cost of Revenue
Gross Profit	1,321	1,616	1,815	1,632	1,958
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,891	2,267	2,435	3,330	2,556
Operating Profit	418	532	640	-546	457
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	389	485	568	-634	362
Provision for Income Taxes
Net Income After Taxes	384	505	557	-673	350
Net Income Before Extraordinary Items
Net Income	384	505	557	-673	350
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	384	505	557	-673	350
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	20.2	26.5	29.3	-5.07	18.4
Dividends per Share